Mycology: An International Journal on Fungal Biology, published by Taylor & Francis Ltd, stands at the forefront of fungal research, facilitating the dissemination of knowledge across the diverse fields of infectious diseases, microbiology, and plant science. Established as an Open Access journal since 2010, it offers researchers free and immediate access to high-quality articles that advance our understanding of fungal biology and its applications. With a commendable ranking in Q2 for Infectious Diseases and Microbiology, and Q1 for Plant Science as of 2023, it positions itself as a vital resource for the global scientific community. The journal, conveniently located in the United Kingdom, is committed to publishing rigorous research that stimulates discussion and fosters collaboration among academics, practitioners, and students alike. By providing a platform for innovative studies and critical reviews, Mycology continues to play an essential role in unraveling the complexities of fungal organisms and their profound implications in health, agriculture, and ecosystem dynamics.

Fungal Biology, published by Elsevier Science Ltd, is a premier journal dedicated to advancing the field of mycology and its interdisciplinary applications. With an ISSN of 1878-6146 and E-ISSN 1878-6162, this journal serves as a vital platform for researchers and professionals interested in the ecological, evolutionary, and genetic aspects of fungi, as well as their implications in infectious diseases and plant sciences. As of 2023, it proudly holds a Q2 ranking in Ecology, Evolution, Behavior and Systematics and Plant Science, and a Q3 ranking in Genetics and Infectious Diseases, highlighting its significant contribution to these domains. The journal boasts an impressive Scopus rank, including a percentile of 83rd in Ecological studies, ensuring that published research reaches a wide audience and impacts ongoing discourse in the field. With open access options, Fungal Biology encourages the dissemination of high-quality research, aimed to foster collaboration and innovation among scholars and practitioners. With its convergence of knowledge from 2010 to 2024, this journal is instrumental for those advancing the understanding of fungal biology and its myriad applications in environmental and health sciences.

Fungal Diversity is a premier academic journal dedicated to advancing the science of mycology, encompassing ecological, evolutionary, and biological research involving fungi. Published by Springer, this journal has established a significant presence in the academic community since its inception in 1998, and it continues to thrive with a convergence period extending to 2024. Holding a prestigious Q1 ranking in several categories — including Ecology, Ecology, Evolution, Behavior and Systematics, and Plant Science — Fungal Diversity showcases cutting-edge research that influences ecological management, conservation, and biodiversity studies. With its notable positions in Scopus rankings, including being ranked #1 in Environmental Science - Ecology, the journal serves as an essential resource for researchers, professionals, and students interested in the complex interplay between fungi and their environments. Although it does not currently offer open access, interested readers can benefit from the journal's rich repository of peer-reviewed articles, making Fungal Diversity a vital component of the scientific literature landscape.

Medical Microbiology and Immunology is a renowned journal published by Springer, serving as a pivotal resource in the fields of microbiology and immunology. Established in 1971 and continuing its legacy through 2024, this journal features cutting-edge research and reviews that address critical advancements and challenges within these dynamic fields. With an impressive impact factor and a robust ranking, including Q1 categories in both Microbiology (medical) and Immunology, it stands at the forefront of scholarly communication, ranking 21st out of 140 in the realm of Medical Microbiology. Researchers and professionals are encouraged to explore a variety of studies that delve into the interactions between microorganisms and the immune system, making it an essential resource for anyone fascinated by these interconnected realms of health sciences. Although not open access, the journal is widely accessible through institutional libraries, ensuring that significant findings reach a global audience. The University of New York Plaza serves as its operational hub in the USA, reinforcing its international influence and dedication to advancing knowledge in microbiology and immunology.

Medical Mycology Case Reports, published by Elsevier, is a pivotal journal dedicated to advancing the field of mycology through the presentation of case reports that highlight clinical findings, diagnostic challenges, and treatment outcomes associated with fungal infections. With its ISSN 2211-7539 and E-ISSN 2211-7539, this open-access journal has been serving the global community since 2012, allowing unrestricted access to its valuable insights. Situated in the Netherlands, specifically at RADARWEG 29, AMSTERDAM, this journal has gained recognition in areas such as Infectious Diseases (ranked Q3) and Microbiology (ranked Q4) as of 2023. Its commitment to disseminating high-quality research is reflected in its Scopus rankings, which place it at the 51st percentile in Medicine and the 32nd percentile in Immunology and Microbiology. By bridging the gap between clinical cases and academic research, Medical Mycology Case Reports plays a crucial role in enriching the knowledge base of practitioners and researchers alike, ultimately contributing to improved patient management and public health.

Reviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.

MycoKeys, published by PENSOFT PUBLISHERS, is a leading open-access journal dedicated to advancing the understanding of fungal biology and its diverse implications within agricultural, ecological, and biological sciences. With its ISSN 1314-4057 and E-ISSN 1314-4049, this journal has achieved remarkable academic prestige, reflected in its 2023 Scopus rankings placing it in the first quartile (Q1) across several categories, including Agricultural and Biological Sciences (miscellaneous), Ecology, Evolution, Behavior and Systematics, and Plant Science. MycoKeys provides a platform for researchers, professionals, and students interested in the latest findings and methodologies regarding fungi, their environments, and their interactions within various ecosystems. Since its transition to open access in 2011, the journal has championed the dissemination of high-quality research to a global audience, fostering collaboration and innovation in mycology. With a publishing history that converges from 2015 to 2024, MycoKeys remains a vital resource for those committed to exploring the multifaceted roles fungi play in our world.

Current Fungal Infection Reports is an essential academic journal dedicated to the rapidly evolving field of mycology, specifically focusing on the diagnosis, treatment, and epidemiology of fungal infections. Published by Springer, this journal aims to provide a comprehensive platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings and insights into the complexities surrounding fungal diseases. With an ISSN of 1936-3761 and an E-ISSN of 1936-377X, the journal is recognized in the Q3 category for Infectious Diseases as of 2023 and holds a Scopus rank of #199 out of 344 in its field, showcasing its growing influence. Although not currently open access, Current Fungal Infection Reports remains an important resource for those wishing to stay updated on key developments and trends within this critical area of global health. Through its commitment to advancing knowledge and fostering academic exchange, the journal plays a crucial role in combating the challenges posed by fungal infections, making it a must-read for anyone involved in infectious disease research and treatment.

SYDOWIA is a prestigious academic journal based in Austria, published by Verlag Ferdinand Berger Sohne Gesellschaft mbH, that has been a cornerstone of scientific publishing since its establishment in 1996. With an ISSN of 0082-0598, SYDOWIA focuses on critical research in the fields of Ecology, Evolution, Behavior and Systematics as well as Plant Science, earning a notable classification in Category Quartiles with Q3 in Ecology-related disciplines and Q2 in Plant Science for 2023. The journal’s strategic insights into agricultural and biological sciences have secured a place within the Scopus rankings, where it holds the position of #191 out of 516 in Plant Science and #278 out of 721 in Ecology categories—reflecting its growing influence with a percentile standing of 63rd and 61st, respectively. Although SYDOWIA is not an Open Access journal, it continues to thrive in delivering scholarly articles that promote advancement and innovation in ecological and botanical research. Researchers, professionals, and students alike can rely on SYDOWIA as a vital resource for disseminating knowledge and fostering exploration in these essential scientific domains.

MEDICAL MYCOLOGY, published by Oxford University Press, is a premier journal dedicated to the study of fungal infections and their clinical implications. With an ISSN of 1369-3786 and an E-ISSN of 1460-2709, this journal has established itself as a vital resource in the fields of Infectious Diseases and Medicine, holding a respectable Q2 ranking for both categories and a Q1 ranking in the veterinary sector in 2023. Spanning a rich history from 1962 to 2024, MEDICAL MYCOLOGY serves as a platform for innovative research, case reports, and review articles that contribute to the understanding and management of mycological diseases. The journal's commitment to advancing knowledge is reflected in its Scopus rank of #120 out of 344 in Medicine - Infectious Diseases, positioning it within the 65th percentile. With open access options available, it aims to ensure that critical research is accessible to a global audience, enhancing collaboration and knowledge sharing among researchers, healthcare professionals, and students alike.